Antibody-based binding domain fused to TCRγ chain facilitates T cell cytotoxicity for potent anti-tumor response
Abstract Chimeric antigen receptor T-cell (CAR-T) therapy has demonstrated potent clinical efficacy in the treatment of hematopoietic malignancies. However, the application of CAR-T in solid tumors has been limited due in part to the expression of inhibitory molecules in the tumor microenvironment,...
| 發表在: | Oncogenesis |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , |
| 格式: | Article |
| 語言: | 英语 |
| 出版: |
Nature Publishing Group
2023-06-01
|
| 在線閱讀: | https://doi.org/10.1038/s41389-023-00480-4 |
